Clinical trial
Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
NCT00359281 · Aegerion Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00359281 |
|---|---|
| Title | Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents |
| Official title | A Phase II, Fixed-sequenced, Open- Label, Research Study to Assess Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Therapies in Healthy Volunteers |
| Lead sponsor | Aegerion Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | atorvastatin, simvastatin, ezetimibe, fenofibrate, dextromethorphan, Extended Release Niacin |
| Enrollment | 125 |
| Start date | Mar 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Aug 2, 2006 |
| Last update posted | Feb 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: